{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:25:28Z","timestamp":1789586728777,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T00:00:00Z","timestamp":1653436800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T00:00:00Z","timestamp":1653436800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-022-02358-8","type":"journal-article","created":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T18:03:47Z","timestamp":1653501827000},"page":"395-400","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Investigating the epidemiological relationship between vitiligo and psoriasis: a population-based study"],"prefix":"10.1007","volume":"315","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9971-9151","authenticated-orcid":false,"given":"Khalaf","family":"Kridin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keren","family":"Lyakhovitsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erez","family":"Onn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Lyakhovitsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orly","family":"Weinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnon D.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,25]]},"reference":[{"key":"2358_CR1","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s40257-017-0298-5","volume":"18","author":"R Speeckaert","year":"2017","unstructured":"Speeckaert R, van Geel N (2017) Vitiligo: an update on pathophysiology and treatment options. Am J Clin Dermatol 18:733\u2013744","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"2358_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaad.2016.10.048","volume":"77","author":"M Rodrigues","year":"2017","unstructured":"Rodrigues M, Ezzedine K, Hamzavi I, Pandya AG, Harris JE (2017) New discoveries in the pathogenesis and classification of vitiligo. J Am Acad Dermatol 77(1):1\u201313","journal-title":"J Am Acad Dermatol"},{"key":"2358_CR3","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/S0140-6736(14)60763-7","volume":"386","author":"K Ezzedine","year":"2015","unstructured":"Ezzedine K, Eleftheriadou V, Whitton M, Van Geel N (2015) Vitiligo. Lancet 386:74\u201384","journal-title":"Lancet"},{"key":"2358_CR4","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/j.1365-2230.2010.03972.x","volume":"36","author":"DA Bassiouny","year":"2011","unstructured":"Bassiouny DA, Shaker O (2011) Role of interleukin-17 in the pathogenesis of vitiligo. Clin Exp Dermatol 36:292\u2013297","journal-title":"Clin Exp Dermatol"},{"key":"2358_CR5","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1111\/ijd.14055","volume":"57","author":"AM Dahir","year":"2018","unstructured":"Dahir AM, Thomsen SF (2018) Comorbidities in vitiligo: comprehensive review. Int J Dermatol 57:1157\u20131164","journal-title":"Int J Dermatol"},{"key":"2358_CR6","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1001\/jama.2020.4006","volume":"323","author":"AW Armstrong","year":"2020","unstructured":"Armstrong AW, Read C (2020) Pathophysiology, clinical presentation, and treatment of psoriasis: a review. J Am Med Assoc 323:1945\u20131960","journal-title":"J Am Med Assoc"},{"key":"2358_CR7","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","volume":"386","author":"WH Boehncke","year":"2015","unstructured":"Boehncke WH, Sch\u00f6n MP (2015) Psoriasis. Lancet 386:983\u2013994","journal-title":"Lancet"},{"key":"2358_CR8","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/jdv.13854","volume":"31","author":"IM Michalek","year":"2017","unstructured":"Michalek IM, Loring B, John SM (2017) A systematic review of worldwide epidemiology of psoriasis. J Eur Acad Dermatol Venereol 31:205\u2013212","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2358_CR9","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1038\/jid.2009.59","volume":"129","author":"A Di Cesare","year":"2009","unstructured":"Di Cesare A, Di Meglio P, Nestle FO (2009) The IL-23Th17 axis in the immunopathogenesis of psoriasis. J Invest Dermatol 129:1339\u20131350","journal-title":"J Invest Dermatol"},{"key":"2358_CR10","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.jaad.2012.04.039","volume":"67","author":"JJ Wu","year":"2012","unstructured":"Wu JJ, Nguyen TU, Poon KYT, Herrinton LJ (2012) The association of psoriasis with autoimmune diseases. J Am Acad Dermatol 67:924\u2013930","journal-title":"J Am Acad Dermatol"},{"key":"2358_CR11","doi-asserted-by":"publisher","first-page":"e23089","DOI":"10.1371\/journal.pone.0023089","volume":"6","author":"KJ Zhu","year":"2011","unstructured":"Zhu KJ, Lv YM, Yin XY, Wang ZX, Sun LD, He SM et al (2011) Psoriasis regression analysis of MHC loci identifies shared genetic variants with vitiligo. PLoS ONE 6:e23089","journal-title":"PLoS ONE"},{"key":"2358_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s40257-018-0394-1","volume":"20","author":"H Yen","year":"2019","unstructured":"Yen H, Chi CC (2019) Association between psoriasis and vitiligo: a systematic review and meta-analysis. Am J Clin Dermatol 20:31\u201340","journal-title":"Am J Clin Dermatol"},{"key":"2358_CR13","doi-asserted-by":"publisher","first-page":"341","DOI":"10.2147\/CCID.S142819","volume":"10","author":"KE Sharquie","year":"2017","unstructured":"Sharquie KE, Salman HA, Yaseen AK (2017) Psoriasis and vitiligo are close relatives. Clin Cosmet Investig Dermatol 10:341\u2013345","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"2358_CR14","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1111\/bjd.14640","volume":"175","author":"HE Teulings","year":"2016","unstructured":"Teulings HE, Ceylan E, Overkamp M, Vrijman C, Bos JD, Nijsten TE et al (2016) Nonsegmental vitiligo disease duration and female sex are associated with comorbidity and disease extent: a retrospective analysis in 1307 patients aged \u2265 50 years. Br J Dermatol 175:821\u2013824","journal-title":"Br J Dermatol"},{"key":"2358_CR15","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/jdv.12117","volume":"28","author":"M Arunachalam","year":"2014","unstructured":"Arunachalam M, Dragoni F, Colucci R, Berti S, Crocetti E, Galeone M et al (2014) Non-segmental vitiligo and psoriasis comorbidity\u2014a case\u2013control study in italian patients. J Eur Acad Dermatol Venereol 28:433\u2013437","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2358_CR16","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1111\/j.1365-4632.2008.03699.x","volume":"47","author":"F Prignano","year":"2008","unstructured":"Prignano F, Pescitelli L, Ricceri F, Lotti T (2008) The importance of genetical link in immuno-mediated dermatoses: psoriasis and vitiligo. Int J Dermatol 47:1060\u20131062","journal-title":"Int J Dermatol"},{"key":"2358_CR17","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jaad.2003.12.014","volume":"51","author":"K Sandhu","year":"2004","unstructured":"Sandhu K, Kaur I, Kumar B (2004) Psoriasis and vitiligo. J Am Acad Dermatol 51:149\u2013150","journal-title":"J Am Acad Dermatol"},{"key":"2358_CR18","doi-asserted-by":"publisher","first-page":"719","DOI":"10.3349\/ymj.2015.56.3.719","volume":"56","author":"H Lee","year":"2015","unstructured":"Lee H, Lee MH, Lee DY, Kang HY, Kim KH, Choi GS et al (2015) Prevalence of vitiligo and associated comorbidities in korea. Yonsei Med J 56:719\u2013725","journal-title":"Yonsei Med J"},{"key":"2358_CR19","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1111\/jdv.12870","volume":"29","author":"YT Chen","year":"2015","unstructured":"Chen YT, Chen YJ, Hwang CY, Lin MW, Chen TJ, Chen CC et al (2015) Comorbidity profiles in association with vitiligo: a nationwide population-based study in taiwan. J Eur Acad Dermatol Venereol 29:1362\u20131369","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2358_CR20","doi-asserted-by":"publisher","first-page":"330","DOI":"10.5021\/ad.2009.21.3.330","volume":"21","author":"JM Park","year":"2009","unstructured":"Park JM, Kim HJ, Bae BG, Park YK (2009) A case of concurrent vitiligo and psoriasis. Ann Dermatol 21:330\u2013333","journal-title":"Ann Dermatol"},{"key":"2358_CR21","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1177\/120347541201600505","volume":"16","author":"M Sawchuk","year":"2012","unstructured":"Sawchuk M, Spano F, Loo WJ, Guenther L (2012) The coexistence of psoriasis and vitiligo: a review. J Cutan Med Surg 16:300\u2013305","journal-title":"J Cutan Med Surg"},{"key":"2358_CR22","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17383","author":"D Canu","year":"2021","unstructured":"Canu D, Shourick J, Andreu N, Gey A, Ballanger-D\u00e9solneux F, Barailler H et al (2021) Demographic and clinical characteristics of patients with both psoriasis and vitiligo in a cohort of vitiligo patients: a cross-sectional study. J Eur Acad Dermatol Venereol. https:\/\/doi.org\/10.1111\/jdv.17383","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2358_CR23","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1093\/oxfordjournals.aje.a113439","volume":"116","author":"S Greenland","year":"1982","unstructured":"Greenland S, Thomas DC (1982) On the need for the rare disease assumption in case-control studies. Am J Epidemiol 116:547\u2013553","journal-title":"Am J Epidemiol"},{"key":"2358_CR24","doi-asserted-by":"publisher","first-page":"511","DOI":"10.3389\/fmed.2020.00511","volume":"7","author":"K Kridin","year":"2020","unstructured":"Kridin K, Ludwig RJ, Schonmann Y, Damiani G, Cohen AD (2020) The bidirectional association between bullous pemphigoid and psoriasis: a population-based cohort study. Front Med 7:511","journal-title":"Front Med"},{"key":"2358_CR25","first-page":"204","volume":"149","author":"AD Cohen","year":"2010","unstructured":"Cohen AD, Dreiher J, Regev-Rosenberg S, Yakovson O, Lieberman N, Goldfracht M et al (2010) The quality indigators program in clalit health services: the first decade. Harefuah 149:204\u2013209","journal-title":"Harefuah"},{"key":"2358_CR26","doi-asserted-by":"publisher","first-page":"e0181039","DOI":"10.1371\/journal.pone.0181039","volume":"12","author":"S Singh","year":"2017","unstructured":"Singh S, Young P, Armstrong AW (2017) An update on psoriasis and metabolic syndrome: a meta-analysis of observational studies. PLoS ONE 12:e0181039","journal-title":"PLoS ONE"},{"key":"2358_CR27","first-page":"94","volume":"9","author":"A Selenyi","year":"1955","unstructured":"Selenyi A (1955) Vitiligo and psoriasis on the same side with syringomyelia. Borgyogy Venerol Sz Hungr 9:94\u201396","journal-title":"Borgyogy Venerol Sz Hungr"},{"key":"2358_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ajo.2010.03.008","volume":"150","author":"SE Soh","year":"2010","unstructured":"Soh SE, Saw SM (2010) Cohort studies: design and pitfalls. Am J Ophthalmol 150:3\u20135","journal-title":"Am J Ophthalmol"},{"key":"2358_CR29","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1046\/j.1523-1747.1998.00107.x","volume":"110","author":"LS Chan","year":"1998","unstructured":"Chan LS, Vanderlugt CJ, Hashimoto T, Nishikawa T, Zone JJ, Black MM et al (1998) Epitope spreading: lessons from autoimmune skin diseases. J Invest Dermatol 110:103\u2013109","journal-title":"J Invest Dermatol"},{"key":"2358_CR30","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1086\/375451","volume":"72","author":"PR Fain","year":"2003","unstructured":"Fain PR, Gowan K, LaBerge GS, Alkhateeb A, Stetler GL, Talbert J et al (2003) A genomewide screen for generalized vitiligo: confirmation of AIS1 on chromosome 1p31 and evidence for additional susceptibility loci. Am J Hum Genet 72:1560\u20131564","journal-title":"Am J Hum Genet"},{"key":"2358_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2016.00003","author":"C Shen","year":"2016","unstructured":"Shen C, Gao J, Sheng Y, Dou J, Zhou F, Zheng X et al (2016) Genetic susceptibility to vitiligo: GWAS approaches for identifying vitiligo susceptibility genes and loci. Front Genet. https:\/\/doi.org\/10.3389\/fgene.2016.00003","journal-title":"Front Genet"},{"key":"2358_CR32","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cytogfr.2019.01.001","volume":"45","author":"D Das","year":"2019","unstructured":"Das D, Akhtar S, Kurra S, Gupta S, Sharma A (2019) Emerging role of immune cell network in autoimmune skin disorders: an update on pemphigus, vitiligo and psoriasis. Cytokine Growth Factor Rev 45:35\u201344","journal-title":"Cytokine Growth Factor Rev"},{"key":"2358_CR33","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/pcmr.12949","volume":"34","author":"J Seneschal","year":"2021","unstructured":"Seneschal J, Boniface K, D\u2019Arino A, Picardo M (2021) An update on vitiligo pathogenesis. Pigment Cell Melanoma Res 34:236\u2013243","journal-title":"Pigment Cell Melanoma Res"},{"key":"2358_CR34","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20193266","author":"Y-Z Ji","year":"2019","unstructured":"Ji Y-Z, Liu S-R (2019) Koebner phenomenon leading to the formation of new psoriatic lesions: evidences and mechanisms. Biosci Rep. https:\/\/doi.org\/10.1042\/BSR20193266"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-022-02358-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-022-02358-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-022-02358-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T12:06:32Z","timestamp":1678968392000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-022-02358-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,25]]},"references-count":34,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["2358"],"URL":"https:\/\/doi.org\/10.1007\/s00403-022-02358-8","relation":{"references":[{"id-type":"uri","id":"","asserted-by":"subject"}]},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,25]]},"assertion":[{"value":"9 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"ADC served as an advisor, investigator, or speaker for Abbvie, BI, Dexcel Pharma, Janssen, Novartis, Perrigo, Pfizer, and Rafa. None of the other authors have any conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}